{"id":"corticorelin","rwe":[{"pmid":"41704485","year":"2026","title":"Defining a serum cortisol cutoff level post-CRH stimulation for diagnosing ACTH deficiency: A retrospective study validated by a nationwide registry.","finding":"","journal":"Frontiers in endocrinology","studyType":"Clinical Study"},{"pmid":"41552350","year":"2025","title":"Transnasal drug delivery to the brain: circumventing barriers for brain tumor patients.","finding":"","journal":"American journal of translational research","studyType":"Clinical Study"},{"pmid":"31860462","year":"2020","title":"Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy.","finding":"","journal":"Clinical chemistry and laboratory medicine","studyType":"Clinical Study"},{"pmid":"27951520","year":"2017","title":"Corticotropin-releasing hormone and dopamine release in healthy individuals.","finding":"","journal":"Psychoneuroendocrinology","studyType":"Clinical Study"},{"pmid":"26500680","year":"2015","title":"Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review.","finding":"","journal":"International journal of pediatric endocrinology","studyType":"Clinical Study"}],"tags":[{"label":"Peptide","category":"modality"},{"label":"Corticotropin-releasing factor receptor 1","category":"target"},{"label":"CRHR1","category":"gene"},{"label":"CRHR2","category":"gene"},{"label":"V04CD04","category":"atc"},{"label":"Active","category":"status"},{"label":"Diagnosis of Hypercortisolism","category":"indication"}],"phase":"marketed","safety":{"commonSideEffects":[{"effect":"Flushing of face, neck, and upper chest","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Tachycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Urticaria","drugRate":"","severity":"common","organSystem":""},{"effect":"Wheezing","drugRate":"","severity":"common","organSystem":""},{"effect":"Angioedema","drugRate":"","severity":"common","organSystem":""},{"effect":"Chest compression or tightness","drugRate":"","severity":"common","organSystem":""},{"effect":"Hypotension","drugRate":"","severity":"common","organSystem":""},{"effect":"Urge to take a deep breath","drugRate":"","severity":"common","organSystem":""},{"effect":"Transient flushing","drugRate":"","severity":"common","organSystem":""},{"effect":"Feelings of dyspnea","drugRate":"","severity":"common","organSystem":""}],"seriousAdverseEvents":[{"effect":"Asystole requiring resuscitation","drugRate":"","severity":"serious"},{"effect":"Precipitous fall in blood pressure and pulse rate","drugRate":"","severity":"serious"},{"effect":"Loss of consciousness (absence-like)","drugRate":"","severity":"serious"},{"effect":"Grand mal epileptic seizure","drugRate":"","severity":"serious"},{"effect":"Significant decrease in blood pressure","drugRate":"","severity":"serious"},{"effect":"Significant increase in heart rate","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CORTICORELIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:31:30.206021+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:31:36.505333+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CORTICORELIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:31:36.818260+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108182/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:31:37.518180+00:00"}},"allNames":"corticotropin-releasing factor (human)","offLabel":[],"synonyms":["corticorelin","corticotropin-releasing factor (human)","corticorelin human","corticorelin acetate"],"timeline":[],"approvals":[],"brandName":"Corticotropin-Releasing Factor (Human)","ecosystem":[{"indication":"Diagnosis of Hypercortisolism","otherDrugs":[],"globalPrevalence":166000000}],"mechanism":{"target":"Corticotropin-releasing factor receptor 1","targets":[{"gene":"CRHR1","source":"DrugCentral","target":"Corticotropin-releasing factor receptor 1","protein":"Corticotropin-releasing factor receptor 1"},{"gene":"CRHR2","source":"DrugCentral","target":"Corticotropin-releasing factor receptor 2","protein":"Corticotropin-releasing factor receptor 2"}],"modality":"Peptide","explanation":"","oneSentence":"","technicalDetail":"CORTICORELIN binds to the corticotropin-releasing factor receptor 1 (CRFR1), a G protein-coupled receptor, triggering a cascade of intracellular signaling events that ultimately lead to the release of adrenocorticotropic hormone (ACTH) and subsequent cortisol production."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4858","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CORTICORELIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CORTICORELIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:18:14.527860","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:31:39.142430+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"metyrapone","drugSlug":"metyrapone","fdaApproval":"1961-12-04","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"sermorelin","drugSlug":"sermorelin","fdaApproval":"1990-12-28","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"macimorelin","drugSlug":"macimorelin","fdaApproval":"2017-12-20","patentExpiry":"Oct 12, 2027","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"corticorelin","indications":{"approved":[{"name":"Diagnosis of Hypercortisolism","source":"DrugCentral","snomedId":"","regulator":"FDA","globalPrevalence":166000000,"prevalenceMethod":"ai-extracted","prevalenceSource":"J Endocrinol Invest, 2022 (PMID:35133616)"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"metyrapone","brandName":"metyrapone","genericName":"metyrapone","approvalYear":"1961","relationship":"same-class"},{"drugId":"sermorelin","brandName":"sermorelin","genericName":"sermorelin","approvalYear":"1990","relationship":"same-class"},{"drugId":"macimorelin","brandName":"macimorelin","genericName":"macimorelin","approvalYear":"2017","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06815471","phase":"PHASE2","title":"CRF2 Agonist for the Treatment of Worsening Heart Failure","status":"RECRUITING","sponsor":"Corteria Pharmaceuticals","startDate":"2025-08-07","conditions":["Worsening Heart Failure"],"enrollment":300,"completionDate":"2026-12"},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":["Chromosome Aberrations","Growth Hormone Deficiency","Hypomyelination"],"enrollment":4000,"completionDate":"2040-12"},{"nctId":"NCT05703425","phase":"PHASE2","title":"The Effect of Sulfasalazine on CRH Levels in Pregnant Women","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-03-01","conditions":["Preterm Birth"],"enrollment":50,"completionDate":"2026-06-30"},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":["Sleep Restriction"],"enrollment":5,"completionDate":"2026-06-24"},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":["Sleep Restriction"],"enrollment":80,"completionDate":"2026-06-30"},{"nctId":"NCT05012072","phase":"NA","title":"Reducing Pregnancy Risks: The Mastery Lifestyle Intervention","status":"RECRUITING","sponsor":"Microgen LLC","startDate":"2021-08-01","conditions":["Mental Health Wellness 1","Preterm Birth"],"enrollment":238,"completionDate":"2026-04-13"},{"nctId":"NCT05008146","phase":"EARLY_PHASE1","title":"Imaging CRF X NOP Interactions in CUD","status":"RECRUITING","sponsor":"Rajesh Narendran","startDate":"2020-12-31","conditions":["Cocaine Use Disorder"],"enrollment":80,"completionDate":"2028-09-01"},{"nctId":"NCT06259227","phase":"NA","title":"Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury","status":"RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2024-01-11","conditions":["Incomplete Spinal Cord Injury","Exercise Training"],"enrollment":32,"completionDate":"2026-02"},{"nctId":"NCT04902235","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-07-06","conditions":["Hypopituitarism","Central Diabetes Insipidus","Panhypopituitarism","Psychological Disorder","Social Isolation","Hypothalamic Diseases","Pituitary Diseases","Oxytocin Deficiency"],"enrollment":52,"completionDate":"2023-05-01"},{"nctId":"NCT02316132","phase":"NA","title":"Confocal Laser Endomicroscopy, IBS and Stress","status":"WITHDRAWN","sponsor":"University Hospital Schleswig-Holstein","startDate":"2014-12","conditions":["Irritable Bowel Syndrome"],"enrollment":0,"completionDate":"2016-07"},{"nctId":"NCT03302416","phase":"EARLY_PHASE1","title":"CRF - Nociceptin Receptor Interactions","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2016-06-01","conditions":["Healthy"],"enrollment":19,"completionDate":"2019-06-01"},{"nctId":"NCT03613129","phase":"PHASE1,PHASE2","title":"Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"LUCINDA BATEMAN, MD","startDate":"2018-07-23","conditions":["Myalgic Encephalomyelitis","Chronic Fatigue Syndrome"],"enrollment":17,"completionDate":"2019-04-30"},{"nctId":"NCT01373372","phase":"NA","title":"Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia","status":"WITHDRAWN","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2016-12","conditions":["Functional Dyspepsia"],"enrollment":0,"completionDate":"2017-03"},{"nctId":"NCT03045978","phase":"","title":"The Association of Hormones and Peptides With Nutritional Consequences in Children With Feeding Difficulty.","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-09","conditions":["Feeding Difficulty"],"enrollment":50,"completionDate":"2017-12"},{"nctId":"NCT01459237","phase":"EARLY_PHASE1","title":"Effects of Hormone Stimulation on Brain Scans for Cushing s Disease","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2011-10-11","conditions":["Pituitary Neoplasm"],"enrollment":30,"completionDate":"2018-06-12"},{"nctId":"NCT00756925","phase":"","title":"Gender and Neural Substrates of Stress and Craving","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2009-02","conditions":["Cocaine Dependence"],"enrollment":19,"completionDate":"2010-08"},{"nctId":"NCT01673087","phase":"PHASE1","title":"Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-10","conditions":["Stress"],"enrollment":256,"completionDate":"2017-08-15"},{"nctId":"NCT00001453","phase":"","title":"Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1995-04-10","conditions":["Cushing's Syndrome"],"enrollment":98,"completionDate":"2014-10-20"},{"nctId":"NCT00385099","phase":"PHASE2","title":"Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-08","conditions":["Irritable Colon"],"enrollment":10,"completionDate":"2007-10-15"},{"nctId":"NCT00376896","phase":"PHASE1","title":"Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11","conditions":["Irritable Colon","Irritable Bowel Syndrome (IBS)"],"enrollment":25,"completionDate":"2008-10"},{"nctId":"NCT01018992","phase":"PHASE2","title":"Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-12","conditions":["Stress Disorders, Post-Traumatic"],"enrollment":267,"completionDate":"2014-08"},{"nctId":"NCT01187511","phase":"PHASE2","title":"CRF1 Antagonist GSK561679 in Alcoholism","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2010-01","conditions":["Alcohol Dependence"],"enrollment":44,"completionDate":"2015-09"},{"nctId":"NCT01984177","phase":"","title":"Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-06","conditions":["Cocaine-Related Disorders","Cocaine Addiction","Substance-Related Disorders"],"enrollment":17,"completionDate":"2016-06"},{"nctId":"NCT02736734","phase":"PHASE4","title":"The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers","status":"COMPLETED","sponsor":"Prof Dr Jan Tack","startDate":"2014-10","conditions":["Esophageal Motility Disorders"],"enrollment":14,"completionDate":"2014-12"},{"nctId":"NCT02674256","phase":"PHASE4","title":"The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-03","conditions":["Sensitivity (Hyper); Gastrointestinal"],"enrollment":15,"completionDate":"2014-05"},{"nctId":"NCT01227980","phase":"PHASE2","title":"Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2010-10","conditions":["Alcohol-Related Disorders","Alcohol Dependence","Alcoholism","Anxiety Disorder"],"enrollment":70,"completionDate":"2014-07"},{"nctId":"NCT02349503","phase":"PHASE1","title":"Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia","status":"WITHDRAWN","sponsor":"Neurocrine Biosciences","startDate":"2015-02","conditions":["Congenital Adrenal Hyperplasia"],"enrollment":0,"completionDate":"2015-10"},{"nctId":"NCT00088166","phase":"PHASE3","title":"XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors","status":"COMPLETED","sponsor":"Celtic Pharma Development Services","startDate":"2004-05","conditions":["Brain Edema","Brain Tumor"],"enrollment":200,"completionDate":"2008-03"},{"nctId":"NCT00226694","phase":"NA","title":"Alcohol and Gender Effects on Stress Circuit Function","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2003-09","conditions":["Alcoholism","Stress","Alcohol Dependence"],"enrollment":96,"completionDate":"2012-08"},{"nctId":"NCT00208897","phase":"NA","title":"Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?","status":"COMPLETED","sponsor":"Emory University","startDate":"1997-12","conditions":["Major Depressive Disorder"],"enrollment":80,"completionDate":"2007-11"},{"nctId":"NCT01369121","phase":"PHASE1,PHASE2","title":"Tolerability Study of Xerecept® in Pediatric Patients","status":"TERMINATED","sponsor":"Celtic Pharma Development Services","startDate":"2010-06","conditions":["Brain Edema","Brain Tumor"],"enrollment":15,"completionDate":"2013-03"},{"nctId":"NCT01763281","phase":"PHASE4","title":"Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2012-10","conditions":["Healthy"],"enrollment":20,"completionDate":"2013-02"},{"nctId":"NCT00744588","phase":"","title":"Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-08","conditions":["Alcohol Dependence"],"enrollment":75,"completionDate":"2012-03"},{"nctId":"NCT00226655","phase":"PHASE3","title":"An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies","status":"COMPLETED","sponsor":"Celtic Pharma Development Services","startDate":"2005-07","conditions":["Brain Edema","Brain Tumor"],"enrollment":112,"completionDate":"2009-04"},{"nctId":"NCT00666068","phase":"NA","title":"Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism","status":"COMPLETED","sponsor":"Max-Planck-Institute of Psychiatry","startDate":"2008-02","conditions":["Hypopituitarism"],"enrollment":30,"completionDate":"2008-12"},{"nctId":"NCT00691522","phase":"PHASE2","title":"Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)","status":"TERMINATED","sponsor":"PharmaNet","startDate":"2008-11","conditions":["Peritumoral Brain Edema","PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS"],"enrollment":60,"completionDate":"2009-10"},{"nctId":"NCT00001543","phase":"","title":"Dynamics of Leptin and Endocrine Function","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1996-03","conditions":["Healthy","Involutional Depression"],"enrollment":230,"completionDate":"2002-06"},{"nctId":"NCT00001180","phase":"","title":"Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1982-03","conditions":["Adrenal Gland Hyperfunction","Adrenal Gland Hypofunction","Cushing's Syndrome","Healthy"],"enrollment":2250,"completionDate":"2005-06"},{"nctId":"NCT00226668","phase":"PHASE3","title":"XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema","status":"WITHDRAWN","sponsor":"Celtic Pharma Development Services","startDate":"2006-01","conditions":["Brain Edema","Brain Tumor"],"enrollment":120,"completionDate":"2008-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000007539","MMSL":"d04013","NDDF":"006760","UNII":"305OE8862Y","CHEBI":"CHEBI:65312","INN_ID":"6666","RXNORM":"1927940","UMLSCUI":"C0010132","chemblId":"CHEMBL2108182","ChEMBL_ID":"CHEMBL2108182","KEGG_DRUG":"D03591","DRUGBANK_ID":"DB05394","PUBCHEM_CID":"16186200","SNOMEDCT_US":"71971001","SECONDARY_CAS_RN":"1312542-61-2"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":20,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V04CD04","allCodes":["V04CD04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41704485","title":"Defining a serum cortisol cutoff level post-CRH stimulation for diagnosing ACTH deficiency: A retrospective study validated by a nationwide registry.","journal":"Frontiers in endocrinology"},{"date":"2025","pmid":"41552350","title":"Transnasal drug delivery to the brain: circumventing barriers for brain tumor patients.","journal":"American journal of translational research"},{"date":"2020 Apr 28","pmid":"31860462","title":"Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy.","journal":"Clinical chemistry and laboratory medicine"},{"date":"2017 Feb","pmid":"27951520","title":"Corticotropin-releasing hormone and dopamine release in healthy individuals.","journal":"Psychoneuroendocrinology"},{"date":"2015","pmid":"26500680","title":"Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review.","journal":"International journal of pediatric endocrinology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Recombinant protein","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:31:39.142430+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}